Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1127122

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS Trusts: Disclosure of Information
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many NHS Trusts have appointed Freedom to Speak Up Guardians; and how many of those are (a) board members and (b) members of human resources staff.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	255384
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>Freedom to Speak Up Guardians have been appointed in all National Health Service trusts in England.</p><p>Appointments to the role are made locally. There is no nationally published data on the number of Freedom to Speak Up Guardians in trusts that are board members or members of human resources staff.</p><p>However, further information on the grade and job role of Freedom to Speak Up Guardians can be found in the National Guardian’s 2018 survey of guardians at the following link:</p><p><a href="https://www.cqc.org.uk/sites/default/files/20181101_ngo_survey2018.pdf" target="_blank">https://www.cqc.org.uk/sites/default/files/20181101_ngo_survey2018.pdf</a></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 21/05/2019 13:05:00 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4657 label Biography information for Anneliese Dodds

1127214

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the draft resolution for consideration by the World Health Assembly in May 2019 on improving the transparency of markets for medicines, vaccines and other health-related technologies, if the Government will withdraw its support for suggested amendments to remove every mention of high prices.
tabling member constituency	Liverpool, Walton
tabling member printed	Dan Carden
uin	255380
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices.</p><p> </p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255381 255382 question first answered 21/05/2019 16:12:54 answering member 4455 label Biography information for Seema Kennedy
tabling member	4651 label Biography information for Dan Carden

1127215

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the draft resolution for consideration by the World Health Assembly in May 2019 on improving the transparency of markets for medicines, vaccines and other health-related technologies, if the Government will take steps to help ensure that the recommendation to member states calls for mandatory rather than voluntary measures.
tabling member constituency	Liverpool, Walton
tabling member printed	Dan Carden
uin	255381
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices.</p><p> </p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255380 255382 question first answered 21/05/2019 16:12:54 answering member 4455 label Biography information for Seema Kennedy
tabling member	4651 label Biography information for Dan Carden

1127216

registered interest
date	16/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if the Government will support the draft resolution for consideration by the World Health Assembly in May 2019 on improving the transparency of markets for medicines, vaccines and other health-related technologies.
tabling member constituency	Liverpool, Walton
tabling member printed	Dan Carden
uin	255382
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The United Kingdom has a long-established and globally-recognised track record of assessing the price of new, innovative medicines by their clinical benefit and value, rather than by their development costs or international reference prices.</p><p> </p><p>The UK will engage constructively with the talks at the World Health Assembly to achieve the best outcome for people here and globally, including in low and middle income countries. Pricing arrangements are the responsibility of Member States and are highly context specific, but the Department supports information sharing and mutual learning initiatives, where appropriate, in seeking to improve value for money for country procurement budgets.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255380 255381 question first answered 21/05/2019 16:12:54 answering member 4455 label Biography information for Seema Kennedy
tabling member	4651 label Biography information for Dan Carden

1126146

registered interest
date	13/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Maternity Services: Safety
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many staff are employed by the Healthcare Safety Investigation Branch to conduct maternity investigations; and how many such staff positions are vacant.
tabling member constituency	East Worthing and Shoreham
tabling member printed	Tim Loughton
uin	253443
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The 2019-20 baseline budget for the Healthcare Safety Investigation Branch (HSIB) maternity programme has been finalised and HSIB have been informed of the outcome.</p><p>The average cost of a HSIB maternity investigation is £19,000 per investigation. This includes the cost of clinical expertise and training for maternity investigators to lead professional investigations.</p><p>69 investigations were referred to the HSIB between 1 April and 30 September 2018. No investigations were completed in that period as the Maternity Directions requires investigations to be completed in six months and there were no referrals received in the first month of the HSIB implementing the maternity programme.</p><p>As from 1 April 2019, the HSIB maternity investigations programme is fully staffed and operational in every healthcare region in England. At the end of April 2019, 147.6 whole time equivalent staff are employed by the HSIB to conduct maternity investigations. There are no staff positions vacant and the figures exclude support from corporate services.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 253440 253441 253442 question first answered 21/05/2019 10:35:49 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	114 label Biography information for Tim Loughton

1126262

registered interest
date	13/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: ICT
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much of the funding allocated to support the roll-out of electronic prescribing and medicines administration systems across the NHS will be allocated during the financial year 2019-2020.
tabling member constituency	St Austell and Newquay
tabling member printed	Steve Double
uin	253646
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>For the financial year 2019-20, £20 million of funding has been allocated to support the implementation of Electronic Prescribing and Medicines Administrations Systems (EPMA) in provider trusts.</p><p>Allocations (between trusts and between systems) are based on a bidding process as usual. NHS Improvement have already received some bids for EPMA funding, which were of a high quality. Trusts have been informed that decisions can be expected in summer.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 253647 question first answered 21/05/2019 10:32:05 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4452 label Biography information for Steve Double

1126263

registered interest
date	13/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: ICT
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of the funding allocated to support the roll-out of electronic prescribing and medicines administration systems across the NHS will be allocated to medicines administration systems.
tabling member constituency	St Austell and Newquay
tabling member printed	Steve Double
uin	253647
answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>For the financial year 2019-20, £20 million of funding has been allocated to support the implementation of Electronic Prescribing and Medicines Administrations Systems (EPMA) in provider trusts.</p><p>Allocations (between trusts and between systems) are based on a bidding process as usual. NHS Improvement have already received some bids for EPMA funding, which were of a high quality. Trusts have been informed that decisions can be expected in summer.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 253646 question first answered 21/05/2019 10:32:05 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4452 label Biography information for Steve Double